KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Xenon Pharmaceuticals (XENE) over the last 13 years, with Q3 2025 value amounting to -$90.9 million.

  • Xenon Pharmaceuticals' Profit After Tax fell 4476.19% to -$90.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$306.3 million, marking a year-over-year decrease of 4355.73%. This contributed to the annual value of -$234.3 million for FY2024, which is 2847.53% down from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Profit After Tax of -$90.9 million as of Q3 2025, which was down 4476.19% from -$84.7 million recorded in Q2 2025.
  • Xenon Pharmaceuticals' 5-year Profit After Tax high stood at -$15.4 million for Q3 2021, and its period low was -$90.9 million during Q3 2025.
  • Moreover, its 5-year median value for Profit After Tax was -$44.7 million (2023), whereas its average is -$45.3 million.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Profit After Tax crashed by 1253371.43% in 2021 and then plummeted by 1486.81% in 2024.
  • Over the past 5 years, Xenon Pharmaceuticals' Profit After Tax (Quarter) stood at -$25.6 million in 2021, then plummeted by 46.28% to -$37.4 million in 2022, then decreased by 19.65% to -$44.7 million in 2023, then plummeted by 46.81% to -$65.7 million in 2024, then plummeted by 38.38% to -$90.9 million in 2025.
  • Its Profit After Tax was -$90.9 million in Q3 2025, compared to -$84.7 million in Q2 2025 and -$65.0 million in Q1 2025.